Jenburkt Pharmaceuticals Ltd. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 134395,
    "name": "Jenburkt Pharma",
    "stock_name": "Jenburkt Pharma",
    "full_name": "Jenburkt Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/jenburkt-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,105.00",
    "chg": 70.65,
    "chgp": "6.83%",
    "dir": 1,
    "prev_price": "1,034.35",
    "mcapval": "458.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524731,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE354A01013",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.31 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/jenburkt-pharma-134395-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Jenburkt Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jenburkt-pharma-technically-bullish-or-bearish-3739982",
        "imagepath": "",
        "date": "2025-12-02 08:23:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Price Action and Trend</strong></p>\n<p>As of the latest trading session, Jenburkt Pharma closed at ₹1,146.65, down from the previous close of ₹1,167.75. The stock's intraday range fluctuated between ₹1,140.00 and ₹1,185.00, reflecting moderate volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹936.70 and a high of ₹1,410.00, indicating a wide trading band and significant price movement over the year.</p>\n<p>The technical trend recently transitioned from a sideways pattern to mildly bearish on 1 December 2025, signalling a subtle shift in market sentiment. This change suggests that the stock may be facing increased selling pressure or a lack of strong buying interest in the near term.</p>\n<p><strong>Technical Indicators: Mixed Signals Acro..."
      },
      {
        "title": "Jenburkt Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-sees-mixed-technical-signals-amid-mild-bearish-momentum-3739883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JenburktPharmac_technicaldot_3739883.png",
        "date": "2025-12-02 08:00:54",
        "description": "Jenburkt Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish stance, underscoring the evolving market dynamics for this Pharmaceuticals & Biotechnology sector stock."
      },
      {
        "title": "Jenburkt Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharma-upgraded-from-sell-to-hold-by-marketsmojo-on-29-oct-2025-3738149",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JenburktPharma_mojoScore_3738149.png",
        "date": "2025-12-01 10:09:02",
        "description": "Jenburkt Pharma's market evaluation has undergone a notable revision, reflecting a shift in analytical perspective driven by recent financial and technical developments. The pharmaceutical microcap's assessment now indicates a more balanced outlook, influenced by its operational performance and valuation considerations within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Jenburkt Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jenburkt-pharma-fallingrising-3726489",
        "imagepath": "",
        "date": "2025-11-25 00:14:38",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Reaction</strong></p>\n<p>Jenburkt Pharma’s share price performance on 24 November reflects a clear trend reversal after a brief rally. The stock underperformed its sector by 3.67% on the day, with the price touching an intraday low of ₹1,170, representing a 5.89% dip from previous levels. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting increased selling pressure as investors booked profits or adjusted positions following recent gains.</p>\n<p>Despite this short-term setback, the stock remains above its 50-day, 100-day, and 200-day moving averages, which typically indicate a longer-term bullish trend. However, it is currently trading below its 5-day and 20-day moving averages, signalling some im..."
      },
      {
        "title": "Is Jenburkt Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jenburkt-pharma-technically-bullish-or-bearish-3716841",
        "imagepath": "",
        "date": "2025-11-20 08:10:12",
        "description": "As of 19 November 2025, the technical trend for Jenburkt Pharma has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD remains bullish, while the monthly MACD is mildly bearish, indicating a divergence in momentum. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bullish on the monthly chart. The daily moving averages are mildly bearish, suggesting short-term weakness. The KST is mildly bullish on the weekly but mildly bearish on the monthly, adding to the mixed signals. Overall, the lack of definitive trends in both the Dow Theory and RSI further supports a neutral outlook...."
      },
      {
        "title": "Jenburkt Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-technical-momentum-shifts-amid-mixed-market-signals-3717067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JenburktPharmac_technicaldot_3717067.png",
        "date": "2025-11-20 08:00:27",
        "description": "Jenburkt Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a mildly bullish trend to a sideways movement, underscoring the need for investors to carefully analyse the evolving technical indicators and price action within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Jenburkt Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jenburkt-pharma-technically-bullish-or-bearish-3713783",
        "imagepath": "",
        "date": "2025-11-19 08:13:17",
        "description": "As of 18 November 2025, the technical trend for Jenburkt Pharma has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive sentiment, while the monthly MACD also confirms this bullish stance. Bollinger Bands indicate a bullish trend on the weekly and a mildly bullish trend on the monthly. However, daily moving averages show a mildly bearish position, which introduces some caution. The KST is mildly bullish on the weekly but mildly bearish on the monthly, indicating mixed signals. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and Bollinger Bands on the weekly timeframe...."
      },
      {
        "title": "Jenburkt Pharmaceuticals Technical Momentum Shifts Signal Market Attention",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-technical-momentum-shifts-to-mildly-bullish-amid-market-volatility-3714089",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JenburktPharmac_technicaldot_3714089.png",
        "date": "2025-11-19 08:00:35",
        "description": "Jenburkt Pharmaceuticals . has exhibited a notable shift in its technical parameters, signalling a change in price momentum that investors and market analysts are closely monitoring. The stock’s recent movement from a sideways trend to a mildly bullish stance is supported by a combination of technical indicators, reflecting evolving market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jenburkt Pharmaceuticals Shows Mixed Technical Trends Amidst Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-price-increase-3709598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JenburktPharmac_technicaldot_3709598.png",
        "date": "2025-11-18 08:00:32",
        "description": "Jenburkt Pharmaceuticals, a microcap in the Pharmaceuticals & Biotechnology sector, has recently revised its evaluation amid changing market conditions. The stock has shown a modest annual return of 2.98%, significantly lower than the Sensex's 9.50%. Despite recent fluctuations, the company has demonstrated strong long-term growth, outperforming the Sensex over five years."
      }
    ],
    "total": 480,
    "sid": "134395",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/jenburkt-pharmaceuticals-134395"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December 2025.",
      "datetime": "28-Jan-2026",
      "details": "Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve standalone unaudited financial results for the quarter and nine months ended On 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended on 31.12.2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Oct-2025",
      "details": "Newspaper Publication for Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jenburkt Pharmaceuticals Ltd. has declared <strong>180%</strong> dividend, ex-date: 11 Jul 25",
          "dt": "2025-07-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Jenburkt Pharma technically bullish or bearish?

2025-12-02 08:23:37

Overview of Current Price Action and Trend As of the latest trading session, Jenburkt Pharma closed at ₹1,146.65, down from the previous close of ₹1,167.75. The stock's intraday range fluctuated between ₹1,140.00 and ₹1,185.00, reflecting moderate volatility. Over the past 52 weeks, the share price has oscillated between a low of ₹936.70 and a high of ₹1,410.00, indicating a wide trading band and significant price movement over the year. The technical trend recently transitioned from a sideways pattern to mildly bearish on 1 December 2025, signalling a subtle shift in market sentiment. This change suggests that the stock may be facing increased selling pressure or a lack of strong buying interest in the near term. Technical Indicators: Mixed Signals Acro...

Jenburkt Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:00:54

Jenburkt Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish stance, underscoring the evolving market dynamics for this Pharmaceuticals & Biotechnology sector stock.

Jenburkt Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-01 10:09:02

Jenburkt Pharma's market evaluation has undergone a notable revision, reflecting a shift in analytical perspective driven by recent financial and technical developments. The pharmaceutical microcap's assessment now indicates a more balanced outlook, influenced by its operational performance and valuation considerations within the Pharmaceuticals & Biotechnology sector.

Why is Jenburkt Pharma falling/rising?

2025-11-25 00:14:38

Short-Term Price Movement and Market Reaction Jenburkt Pharma’s share price performance on 24 November reflects a clear trend reversal after a brief rally. The stock underperformed its sector by 3.67% on the day, with the price touching an intraday low of ₹1,170, representing a 5.89% dip from previous levels. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting increased selling pressure as investors booked profits or adjusted positions following recent gains. Despite this short-term setback, the stock remains above its 50-day, 100-day, and 200-day moving averages, which typically indicate a longer-term bullish trend. However, it is currently trading below its 5-day and 20-day moving averages, signalling some im...

Is Jenburkt Pharma technically bullish or bearish?

2025-11-20 08:10:12

As of 19 November 2025, the technical trend for Jenburkt Pharma has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD remains bullish, while the monthly MACD is mildly bearish, indicating a divergence in momentum. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bullish on the monthly chart. The daily moving averages are mildly bearish, suggesting short-term weakness. The KST is mildly bullish on the weekly but mildly bearish on the monthly, adding to the mixed signals. Overall, the lack of definitive trends in both the Dow Theory and RSI further supports a neutral outlook....

Jenburkt Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals

2025-11-20 08:00:27

Jenburkt Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a mildly bullish trend to a sideways movement, underscoring the need for investors to carefully analyse the evolving technical indicators and price action within the Pharmaceuticals & Biotechnology sector.

Is Jenburkt Pharma technically bullish or bearish?

2025-11-19 08:13:17

As of 18 November 2025, the technical trend for Jenburkt Pharma has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive sentiment, while the monthly MACD also confirms this bullish stance. Bollinger Bands indicate a bullish trend on the weekly and a mildly bullish trend on the monthly. However, daily moving averages show a mildly bearish position, which introduces some caution. The KST is mildly bullish on the weekly but mildly bearish on the monthly, indicating mixed signals. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and Bollinger Bands on the weekly timeframe....

Jenburkt Pharmaceuticals Technical Momentum Shifts Signal Market Attention

2025-11-19 08:00:35

Jenburkt Pharmaceuticals . has exhibited a notable shift in its technical parameters, signalling a change in price momentum that investors and market analysts are closely monitoring. The stock’s recent movement from a sideways trend to a mildly bullish stance is supported by a combination of technical indicators, reflecting evolving market sentiment within the Pharmaceuticals & Biotechnology sector.

Jenburkt Pharmaceuticals Shows Mixed Technical Trends Amidst Market Evaluation Revision

2025-11-18 08:00:32

Jenburkt Pharmaceuticals, a microcap in the Pharmaceuticals & Biotechnology sector, has recently revised its evaluation amid changing market conditions. The stock has shown a modest annual return of 2.98%, significantly lower than the Sensex's 9.50%. Despite recent fluctuations, the company has demonstrated strong long-term growth, outperforming the Sensex over five years.

View All News